EW Edwards Lifesciences
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Edwards Lifesciences (EW) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $50.3 billion. Shares last traded at $87.36, near their 52-week high. Over the past year the stock is up 19.2%. EW trades at a price-to-earnings ratio of 46.86, above the Orthopedic, Prosthetic & Surgical Appliances & Supplies median of 24.15. Net profit margin is 17.7%, above the peer median of 7.7%. Revenue grew 11.5% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.66 | 2026-05-06 |
| FY 2025 | $1.83 | 2026-02-25 |
| Q3 2025 | $1.67 | 2025-11-05 |
| Q2 2025 | $1.18 | 2025-08-06 |
| Q1 2026 | $0.61 | 2026-05-06 |
| FY 2025 | $6.97 | 2026-02-25 |
Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
EW vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap.
| ISRG | Intuitive Surgical | $144.0B | 50.41 | 14.30 | 28.4% | +1.06% |
| EW | Edwards Lifesciences | $50.3B | 46.86 | 8.29 | 17.7% | +0.80% |
| STE | Steris | $19.8B | 25.27 | 3.33 | 13.2% | +1.60% |
| ZBH | Zimmer Biomet | $17.0B | 24.15 | 2.07 | 8.6% | +1.01% |
| ALGN | Align Technology | $13.0B | 31.81 | 3.23 | 10.2% | +4.95% |
| MSA | Msa Safety Inc | $6.3B | 22.75 | 3.38 | 14.9% | +2.63% |
| ESTA | Establishment Labs Holdings Inc. | $2.5B | -48.85 | 11.82 | -24.2% | +2.90% |
| ENOV | Enovis Corp | $1.3B | -1.07 | 0.56 | -52.7% | +5.37% |
| CDRE | Cadre Holdings, Inc. | $1.2B | 27.38 | 1.98 | 7.2% | +0.04% |
| AVNS | Avanos Medical, Inc. | $1.2B | -16.01 | 1.66 | -10.4% | +0.08% |
| AVR | Anteris Technologies Global Corp. | $952M | — | — | — | +3.16% |
| CNXU | Conexeu Sciences Inc. | $348M | — | — | — | +1.56% |
| SMTI | Sanara MedTech Inc. | $201M | 5.34 | 1.94 | 36.4% | +2.72% |
| INGN | Inogen Inc | $174M | 7.63 | 0.59 | 7.7% | +0.79% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.